AbCellera Biologics ABCL Stock
2.57 USD
{{ price }}
-1.153845%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
774.77M USD
LOW - HIGH [24H]
2.54
-
2.64 USD
VOLUME [24H]
2.98M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.55 USD
AbCellera Biologics Price Chart
AbCellera Biologics ABCL Financial and Trading Overview
| AbCellera Biologics stock price | 2.57 USD |
| Previous Close | 7.39 USD |
| Open | 7.35 USD |
| Bid | 0 USD x 2200 |
| Ask | 0 USD x 1200 |
| Day's Range | 7.29 - 7.49 USD |
| 52 Week Range | 5.53 - 14.97 USD |
| Volume | 1.96M USD |
| Avg. Volume | 2.2M USD |
| Market Cap | 2.16B USD |
| Beta (5Y Monthly) | -0.124135 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.55 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 26.5 USD |
ABCL Valuation Measures
| Enterprise Value | 1.33B USD |
| Trailing P/E | N/A |
| Forward P/E | -12.466666 |
| PEG Ratio (5 yr expected) | -1.38 |
| Price/Sales (ttm) | 11.929656 |
| Price/Book (mrq) | 1.7852029 |
| Enterprise Value/Revenue | 7.367 |
| Enterprise Value/EBITDA | -30.344 |
Trading Information
AbCellera Biologics Stock Price History
| Beta (5Y Monthly) | -0.124135 |
| 52-Week Change | -26.086% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 14.97 USD |
| 52 Week Low | 5.53 USD |
| 50-Day Moving Average | 6.77 USD |
| 200-Day Moving Average | 9.42 USD |
ABCL Share Statistics
| Avg. Volume (3 month) | 2.2M USD |
| Avg. Daily Volume (10-Days) | 2.64M USD |
| Shares Outstanding | 288.73M |
| Float | 209.67M |
| Short Ratio | 8.49 |
| % Held by Insiders | 28.64% |
| % Held by Institutions | 46.47% |
| Shares Short | 25.97M |
| Short % of Float | 12.55% |
| Short % of Shares Outstanding | 8.98% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -27.70% |
| Operating Margin (ttm) | -40.49% |
| Gross Margin | 13.85% |
| EBITDA Margin | -24.27% |
Management Effectiveness
| Return on Assets (ttm) | -2.96% |
| Return on Equity (ttm) | -4.15% |
Income Statement
| Revenue (ttm) | 181.04M USD |
| Revenue Per Share (ttm) | 0.63 USD |
| Quarterly Revenue Growth (yoy) | -96.099% |
| Gross Profit (ttm) | 311.11M USD |
| EBITDA | -43953000 USD |
| Net Income Avi to Common (ttm) | -50164000 USD |
| Diluted EPS (ttm) | -0.18 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 796.49M USD |
| Total Cash Per Share (mrq) | 2.76 USD |
| Total Debt (mrq) | 83.13M USD |
| Total Debt/Equity (mrq) | 6.88 USD |
| Current Ratio (mrq) | 10.499 |
| Book Value Per Share (mrq) | 4.19 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 133.08M USD |
| Levered Free Cash Flow (ttm) | 85.71M USD |
Profile of AbCellera Biologics
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 2215 Yukon Street |
| ZIP | V5Y 0A1 |
| Phone | N/A |
| Website | https://www.abcellera.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 525 |
AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners. It has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
Q&A For AbCellera Biologics Stock
What is a current ABCL stock price?
AbCellera Biologics ABCL stock price today per share is 2.57 USD.
How to purchase AbCellera Biologics stock?
You can buy ABCL shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AbCellera Biologics?
The stock symbol or ticker of AbCellera Biologics is ABCL.
Which industry does the AbCellera Biologics company belong to?
The AbCellera Biologics industry is Biotechnology.
How many shares does AbCellera Biologics have in circulation?
The max supply of AbCellera Biologics shares is 301.47M.
What is AbCellera Biologics Price to Earnings Ratio (PE Ratio)?
AbCellera Biologics PE Ratio is now.
What was AbCellera Biologics earnings per share over the trailing 12 months (TTM)?
AbCellera Biologics EPS is -0.55 USD over the trailing 12 months.
Which sector does the AbCellera Biologics company belong to?
The AbCellera Biologics sector is Healthcare.
AbCellera Biologics ABCL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| NASDAQ Global Select Market Com NQGS | 8504.39 USD — |
+1.34
|
— — | 8367.19 USD — | 8515.13 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4148.65 USD — |
+0.54
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
| NASDAQ Biotechnology NBI | 4131.38 USD — |
-1.41
|
— — | 4109.33 USD — | 4165.2 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
- {{ link.label }} {{link}}